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West AfricaThe sternal localization of bone and joint tuberculosis (TB) is rare, has an insidious clinical
presentation, and usually affects young adults living in endemic areas. Mycobacterium afri-
canum causes a relevant proportion of human TB inWest Africa and in migrants from ende-
mic countries. Here, we report two cases of sternal osteomyelitis due to M. africanum in
migrants.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
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licenses/by-nc-nd/4.0/).Case report 1 the body of the sternum. Markers of inflammation wereIn June 2014, a 33-year-old man was admitted to the Infec-
tious and Tropical Disease Unit of Careggi Hospital, Florence,
Italy. He came from Senegal and had been living in Spain and
Germany before moving to Italy in February 2014. He reported
weight loss and sweats for approximately 1 month and, in the
previous 7 days, fever (39 C) and swelling of neck lymph
nodes. Physical examination revealed a fluctuant mass overincreased: C-reactive protein (CRP), 92 mg/L; erythrocyte sed-
imentation rate (ERS), 38 mm/h; and plasma fibrinogen,
540 mg/dL. The QuantiFERON-TB Gold (QFT) (Qiagen, Hilden,
Germany) test was strongly positive (4.19 UI/mL). An echogra-
phy of the neck revealed colliquative lymph nodes, and a
chest radiography showed an apical right-pulmonary lesion.
Computed tomography (CT) of the neck, chest, and abdomen
showed a hypodense lesion in the presternal region, extend-.
Fig. 2 – Computed tomography scan showing an
osteomyelitis of the sternal body and a presternal abscess.
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CT showed involvement of the cervical, dorsal, and lumbar
spine, with multiple paravertebral abscesses compatible with
tubercular osteomyelitis. Needle aspiration of the sternal
abscess was positive for acid-fast bacilli (AFB), and the poly-
merase chain reaction (PCR) assay forMycobacterium tuberculo-
sis complex scored positive. The patient started first-line
antitubercular therapy. The culture grewMycobacterium africa-
num after 2 weeks of incubation. Susceptibility testing
showed isoniazid resistance, therefore, isoniazid was dis-
missed. The respiratory specimens were also positive for M.
africanum. The therapy was stopped after 12 months, with
complete regression of sternal swelling, fever, and sweats,
and normal values of the inflammatory markers. Whole-
genome sequencing (WGS) assigned the strain to the spoligo-
type M. africanum West Africa Type 2 (MAF2) and confirmed
the resistance to isoniazid.
Case report 2
In January 2015, a 21-year-old man from Senegal, in Italy since
August 2014, was hospitalized. The patient reported a sternal
trauma in November 2014, followed by painful swelling. Blood
exams revealed a CRP of 29 mg/L, an ERS of 35 mm/h, and a
normal value of fibrinogen (448 mg/dL). The QFT test scored
positive (3.06 UI/mL). In the Emergency Department, he
received a chest CT scan showing an osteolytic lesion of theFig. 1 – Computed tomography scan of the neck and chest,
showing the presternal lesion extending into soft tissue.sternal body and a presternal abscess (Fig. 2). No other organ
was involved. A needle aspiration was positive according to
AFB microscopy and PCR for M. tuberculosis complex. He
started antitubercular first-line therapy. The culture was also
positive, growing M. africanum after 3 weeks, which turned
out to be susceptible to first-line antitubercular drugs. The
therapy was stopped after 12 months, with complete regres-
sion of sternal swelling and pain. This strain was also
assigned by WGS to the clade MAF2, although in a phyloge-
netic position very distant from that of the strain involved
in Case report 1.
Discussion
In 2013, an estimated 9 million people developed tuberculosis
(TB), with 6.1 million cases reported to theWorld Health Orga-
nization. Of these, 5.4 million were newly diagnosed cases,
and among them, 800,000 were diagnosed with extrapul-
monary TB (EP-TB) [1]. Although bone and joint TB is consid-
ered the third most frequent localization of EP-TB,
involvement of the sternum is rare [2,3]. Its incidence ranges
from 0% to 7%, has insidious clinical presentation, and is
characterized by sternal pain and swelling [4]. Sternal TB
can arise from either direct extension (hilar lymph nodes) or
latent TB reactivation. Sternal TB usually affects young adults
living in endemic areas and recognizes as risk factors open-
heart surgery, human immunodeficiency virus (HIV) infec-
tion, intravenous-drug abuse, and Bacillus Calmette–Gue´rin
vaccination [5]. Sternal radiography (Rx) can show bone loss,
and CT more accurately characterizes soft-tissue involve-
ment, but it is not superior to Rx in highlighting sternal
involvement. Magnetic resonance (MR) images can show
inflammatory changes in the medulla of the bone and allow
discrimination between the reaction of the periosteum to
the soft-tissue inflammation and osteomyelitis [6].
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Senegal and causes a sizeable proportion of human TB in
West Africa [7]. Within the species M. africanum, two spoligo-
types are present: (MAF1) prevalent around the Gulf of Gui-
nea, and MAF2, prevalent in more western African countries
[8]. In industrialized countries, its isolation was related to
immigration from endemic countries, but in some cases, its
dissemination was possible to native-born people and to
immigrants from other regions [9,10]. The geographic restric-
tion of M. africanum could be due to its adaptation to particu-
lar human populations in that region [11]. In Ghana, an ethnic
polymorphism was associated with protection against
Euro–American M. tuberculosis, but not against M. africanum
and M. bovis, and this polymorphism may have allowed the
establishment of M. africanum in West Africa [12]. A study
compared the host-immunological response of Gambian
HIV-negative patients to M. africanum and M. tuberculosis:
before treatment in M. africanum infected patients, higher
levels of tumor necrosis factor-a-producing CD4 and CD8 T
cells were detected along with lower levels of interleukin-2-
producing T cells, and after treatment, higher levels of acti-
vated T cells were persistently observed compared with those
observed in TB patients [13]. MAF2 patients and household
contacts were less likely to produce interferon-c in an early
secreted antigenic target-ESAT-6/culture filtrate protein-
CFP-10 ELISPOT assay, and pathogen-related factors could be
responsible for the lower response [14].
The clinical manifestations of M. africanum are similar to
those of M. tuberculosis. Multiple localizations were reported
for EP-TB due to M. africanum; including disseminated, cuta-
neous, genitourinary, pleural, osteoarticular, and brain mass
[8]. To the best of our knowledge, this is the first report of ster-
nal osteomyelitis caused by M. africanum. Although no data
are available concerning the bone tropism of M. africanum,
in both our case reports, this rare species of M. tuberculosis
complex determined sternal osteomyelitis, suggesting a pos-
sible sternal tropism of M. africanum. In Europe, the increase
of immigration from West Africa may account for an increas-
ing incidence of TB due toM. africanum, and knowledge of the
epidemiology could be helpful for the diagnosis of rare TB
clinical manifestations.
Ethical standards
All persons gave their informed consent prior to their inclu-
sion in the present article.
Conflicts of interest
The authors declare that they have no conflicts of interest.R E F E R E N C E S[1] World Health Organization (WHO), Global Tuberculosis
Report 2014, WHO, Geneva, 2014. Available from: http://www.
who.int/tb/publications/globalreport/en/ (last access:
December 2015).
[2] A. Sandgren, V. Hollo, M.J. van der Werf, Extrapulmonary
tuberculosis in the European Union and European Economic
Area, 2002 to 2011, Euro. Surveill. 18 (2013). pii: 20431.
[3] H.M. Peto, R.H. Pratt, T.A. Harrington, et al, Epidemiology of
extrapulmonary tuberculosis in the United States, 1993–2006,
Clin. Infect. Dis. 49 (2009) 1350–1357.
[4] D.G. McLellan, K.B. Philips, C.E. Corbett, et al, Sternal
osteomyelitis caused by Mycobacterium tuberculosis: case
report and review of the literature, Am. J. Med. Sci. 319 (2000)
250–254.
[5] D.M. de Carli, M.D. Severo, C.J. Haygert, et al, Sternal
osteomyelitis caused by infection with Mycobacterium
tuberculosis, J. Bras. Pneumol. 35 (2009) 709–712.
[6] C. Atasoy, P.S. Oztekin, N. Ozdemir, et al, CT and MRI in
tuberculous sternal osteomyelitis: a case report, Clin.
Imaging 26 (2002) 112–115.
[7] M. Castets, H. Boisvert, F. Grumbach, et al, Tuberculosis bacilli
of the African type: preliminary note, Rev. Tuberc. Pneumol.
32 (1968) 179–184 (Article in French).
[8] B.C. de Jong, M. Antonio, S. Gagneux, Mycobacterium
africanum—review of an important cause of human
tuberculosis in West Africa, PLoS Negl. Trop. Dis. 4 (2010)
e744.
[9] M.C. Isea-Pena, M.F. Brezmes-Valdivieso, M.C. Gonzalez-
Velasco, et al, Mycobacterium africanum, an emerging disease
in high-income countries?, Int J. Tuberc. Lung. Dis. 16 (2012)
1400–1404.
[10] E. Desmond, A.T. Ahmed, W.S. Probert, et al, Mycobacterium
africanum cases, California, Emerg. Infect. Dis. 10 (2004) 921–
923.
[11] A. Asante-Poku, D. Yeboah-Manu, I.D. Otchere, et al,
Mycobacterium africanum is associated with patient ethnicity
in Ghana, PLoS Negl. Trop. Dis. 9 (2015) e3370.
[12] C.D. Intemann, T. Thye, S. Niemann, et al, Autophagy gene
variant IRGM -261T contributes to protection from
tuberculosis caused by Mycobacterium tuberculosis, but not by
M. africanum strains, PLoS Pathog. 5 (2009) e1000577.
[13] L.D. Tientcheu, J.S. Sutherland, B.C. de Jong, et al, Differences
in T-cell responses between Mycobacterium tuberculosis and
Mycobacterium africanum-infected patients, Eur. J. 44 (2014)
1387–1398.
[14] B.C. de Jong, P.C. Hill, R.H. Brookes, et al, Mycobacterium
africanum elicits an attenuated T cell response to early
secreted antigenic target, 6 kDa, in patients with tuberculosis
and their household contacts, J. Infect. Dis. 193 (2006) 1279–
1286.
